NovaBridge Biosciences (NBP) financial statements and ratios from SEC XBRL: revenue $7.61M (TTM), net margin -607.9%, revenue growth 1.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $7.61M |
| Net Margin | -607.9% |
| Return on Equity | -20.0% |
| Current Ratio | 8.09 |
| Revenue Growth (YoY) | 1.7% |
| EPS Growth (YoY) | 75.0% |
| EV / EBITDA | -3.4 |
| Price / Book | 2.30 |
| Price / Sales | 69.74 |
| Altman Z-Score | 3.29 (safe) |
| Sector P/E (Healthcare) | 21.7 |
NBP overview · NBP earnings · NBP KPIs · NBP investor relations · NBP ownership · NBP peers · NBP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.